GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: FG-2101 is a non-hydroxamate antibacterial candidate designed to selectively inhibit bacterial UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) and it is one of the compounds claimed in Blacksmith Medicine's patent WO2023055686A1 [2]. FG-2101 is being developed for intravenous and oral routes of administration to treat Gram-negative bacteria infections. The name to structure was confirmed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[4-[(2S)-3-(3-cyanoazetidin-1-yl)-2-[4-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]phenyl]propyl]-6-oxo-1H-pyrimidin-5-yl] dihydrogen phosphate |
Database Links ![]() |
|
CAS Registry No. | 2919723-66-1 (source: Scifinder) |
PubChem CID | 168181248 |
Search Google for chemical match using the InChIKey | MTAPQGVXYZUOBV-HHHXNRCGSA-N |
Search Google for chemicals with the same backbone | MTAPQGVXYZUOBV |
UniChem Compound Search for chemical match using the InChIKey | MTAPQGVXYZUOBV-HHHXNRCGSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MTAPQGVXYZUOBV-HHHXNRCGSA-N |